A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...
Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant ...
Short interval circulating tumor DNA (ctDNA) kinetics as a predictor of tumor response in patients with gastrointestinal (GI) cancer receiving immune checkpoint inhibitor (ICI)-based treatment. This ...
Site-specific therapy guided by gene-expressing profiling (GEP) could improve outcomes for patients with previously untreated cancers of unknown primary (CUP), Chinese researchers suggested. In their ...
Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of regRNAs ever compiled, uncovering thousands of previously undiscovered regRNAs in human cells ...
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results